{"id":{"repo_id":"msu","oai_identifier":"oai:d.lib.msu.edu:etd_53203"},"canonical_url":"https://search.ndltd.org/etd/msu/oai:d.lib.msu.edu:etd_53203","repository":{"repo_id":"msu","name":"Michigan State University","base_url":"https://d.lib.msu.edu/oai"},"display":{"title":"Targeting the Untouchable : Pre-Clinical Development Of Alpha-Particle Therapy For Metastatic Ovarian Cancer","abstract":"Thesis (Ph.D.)--Michigan State University. Biomedical Engineering - Doctor of Philosophy, 2026","abstract_html":"Thesis (Ph.D.)--Michigan State University. Biomedical Engineering - Doctor of Philosophy, 2026","abstract_has_math":false,"creators":["Xu, Lu"],"institution":null,"degree_name":null,"degree_level":null,"degree_discipline":null,"degree_department":null,"school":null,"contributors":["Zinn, Kurt","Horibata, Sachi","Alessio, Adam","Kim, Taeho"],"advisors":[],"committee_chairs":[],"committee_members":[],"year":2026,"date_issued":"2026","date_published":"2026","updated_at":"2026-11-18T18:59:41Z","subjects":["Biomedical engineering","Medical imaging","Nuclear engineering","Diagnostic imaging"],"languages":["eng"],"rights":["Attribution 4.0 International"],"rights_urls":[],"identifier_entries":[{"key":"dc:identifier","label":"Identifier","values":["etd:53203","local:Xu_grad.msu_0128D_22213"],"render_values":[{"text":"etd:53203","href":null,"code":true},{"text":"local:Xu_grad.msu_0128D_22213","href":null,"code":true}]}],"person_identifier_entries":[]},"links":{"outbound_url":"https://doi.org/doi:10.25335/7gwq-x577","outbound_label":"DOI","outbound_source":"dc:identifier","record_url":"https://doi.org/doi:10.25335/7gwq-x577","record_label":"Repository record","record_kind":"doi","record_source":"dc:identifier","download_url":null,"download_label":null,"download_source":null,"access_status":null,"embargo_until":null,"access_note":null},"source_record":{"url":"https://d.lib.msu.edu/oai?verb=GetRecord&metadataPrefix=oai_dc&identifier=oai%3Ad.lib.msu.edu%3Aetd_53203","prefix":"oai_dc"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:contributor","label":"Contributor","values":["Zinn, Kurt","Horibata, Sachi","Alessio, Adam","Kim, Taeho"]},{"key":"dc:creator","label":"Author","values":["Xu, Lu"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date","label":"Dc Date","values":["2026"]},{"key":"dc:relation","label":"Dc Relation","values":["Electronic Theses & Dissertations"]},{"key":"dc:type","label":"Dc Type","values":["text","Electronic dissertations"]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["Biomedical engineering","Medical imaging","Nuclear engineering","Diagnostic imaging"]}]},{"id":"language_rights","label":"Language and Rights","entries":[{"key":"dc:language","label":"Dc Language","values":["eng"]},{"key":"dc:rights","label":"Dc Rights","values":["Attribution 4.0 International"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier","label":"Identifier","values":["etd:53203","local:Xu_grad.msu_0128D_22213","https://doi.org/doi:10.25335/7gwq-x577"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description","label":"Description","values":["Thesis (Ph.D.)--Michigan State University. Biomedical Engineering - Doctor of Philosophy, 2026","Ovarian cancer (OC) is frequently diagnosed at an advanced stage and characterized by high rates of recurrence despite aggressive cytoreductive surgery and chemotherapy. Relapse is driven by microscopic residual tumors that are disseminated most often throughout the peritoneal cavity, posing significant challenges with conventional systemic therapy. Targeted-alpha particle therapy (TAT) combines molecular targeting with alpha-emitting radionuclides to deliver highly potent and localized cellular damage, uniquely suited for the eradication of small OC tumor clusters within the peritoneal cavity. This dissertation studied hAnnA1 antibody, a humanized antibody against Annexin A1 (ANXA1) expressed on tumor vascular endothelium and cancer cells, also shown to actively target cancer for potentially better therapeutic outcomes. Immune-competent murine OC models using spheroid implantation were developed to evaluate the distribution and tumor uptake of hAnnA1 antibody following intraperitoneal injection. The in vivo uptake of hAnnA1 was assessed using the developed model and in vitro efficacy of TAT using Bi-213 labelled hAnnA1 for murine OC cells. In this dissertation, the hAnnA1 antibody was demonstrated to be a promising precision targeting agent for OC, enabling both fluorescence and PET imaging of high specific tumor uptake in immune-competent mouse models with minimal off-target binding. Bi-213-DTPA-hAnnA1 TAT was effective at inhibiting OC growth and induced cell death through dsDNA damage and dysregulation of cell cycle checkpoint markers without upregulating radio-resistance and epithelial-mesenchymal transition. Together, these findings support the clinical translation potential of Bi-213-DTPA-hAnnA1 for advanced OC and suggest the broader applicability for the treatment of other disseminated solid tumors.","Description based on online resource. Title from PDF t.p. (Michigan State University Fedora Repository, viewed ).","Includes bibliographical references."]},{"key":"dc:format","label":"Dc Format","values":["application/pdf","1 online resource (192 p.) : ill."]},{"key":"dc:title","label":"Title","values":["Targeting the Untouchable : Pre-Clinical Development Of Alpha-Particle Therapy For Metastatic Ovarian Cancer"]}]}],"canonical_facts":{"dc:contributor":["Zinn, Kurt","Horibata, Sachi","Alessio, Adam","Kim, Taeho"],"dc:creator":["Xu, Lu"],"dc:date":["2026"],"dc:description":["Thesis (Ph.D.)--Michigan State University. Biomedical Engineering - Doctor of Philosophy, 2026","Ovarian cancer (OC) is frequently diagnosed at an advanced stage and characterized by high rates of recurrence despite aggressive cytoreductive surgery and chemotherapy. Relapse is driven by microscopic residual tumors that are disseminated most often throughout the peritoneal cavity, posing significant challenges with conventional systemic therapy. Targeted-alpha particle therapy (TAT) combines molecular targeting with alpha-emitting radionuclides to deliver highly potent and localized cellular damage, uniquely suited for the eradication of small OC tumor clusters within the peritoneal cavity. This dissertation studied hAnnA1 antibody, a humanized antibody against Annexin A1 (ANXA1) expressed on tumor vascular endothelium and cancer cells, also shown to actively target cancer for potentially better therapeutic outcomes. Immune-competent murine OC models using spheroid implantation were developed to evaluate the distribution and tumor uptake of hAnnA1 antibody following intraperitoneal injection. The in vivo uptake of hAnnA1 was assessed using the developed model and in vitro efficacy of TAT using Bi-213 labelled hAnnA1 for murine OC cells. In this dissertation, the hAnnA1 antibody was demonstrated to be a promising precision targeting agent for OC, enabling both fluorescence and PET imaging of high specific tumor uptake in immune-competent mouse models with minimal off-target binding. Bi-213-DTPA-hAnnA1 TAT was effective at inhibiting OC growth and induced cell death through dsDNA damage and dysregulation of cell cycle checkpoint markers without upregulating radio-resistance and epithelial-mesenchymal transition. Together, these findings support the clinical translation potential of Bi-213-DTPA-hAnnA1 for advanced OC and suggest the broader applicability for the treatment of other disseminated solid tumors.","Description based on online resource. Title from PDF t.p. (Michigan State University Fedora Repository, viewed ).","Includes bibliographical references."],"dc:format":["application/pdf","1 online resource (192 p.) : ill."],"dc:identifier":["etd:53203","local:Xu_grad.msu_0128D_22213","https://doi.org/doi:10.25335/7gwq-x577"],"dc:language":["eng"],"dc:relation":["Electronic Theses & Dissertations"],"dc:rights":["Attribution 4.0 International"],"dc:subject":["Biomedical engineering","Medical imaging","Nuclear engineering","Diagnostic imaging"],"dc:title":["Targeting the Untouchable : Pre-Clinical Development Of Alpha-Particle Therapy For Metastatic Ovarian Cancer"],"dc:type":["text","Electronic dissertations"]},"updated_at":"2026-11-18T18:59:41Z"}